Cover Image
市場調查報告書

預防診斷的全球市場

Predictive Diagnostics

出版商 Global Industry Analysts, Inc. 商品編碼 289121
出版日期 內容資訊 英文 175 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
預防診斷的全球市場 Predictive Diagnostics
出版日期: 2015年04月01日 內容資訊: 英文 175 Pages
簡介

本報告提供全球預防診斷市場相關調查,提供您2014∼2020年的市場趨勢預測,產品概要,各地區趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 徵兆
    • 預防診斷:遺傳基因檢驗的重要市場區隔
    • 預防診斷市場今後的預測
  • 主要的市場趨勢,促進要素,課題
    • 預防遺傳基因診斷前景看好
    • CSS的發病率及罹患率高:主要推動市場成長要素
    • 癌症診斷數量的增加
    • 預防診斷:乳癌管理重要
    • 神經退化性疾病的發病率上升
    • 老年癡呆症
    • 亨丁頓舞蹈症
    • 帕金森氏症
    • 全球的人口擴大是一大成長機會
    • 預防診斷延緩壽命 其他
  • 產品概要
  • 產品引進
  • 近幾年的產業活動
  • 主要企業
    • Abbott Molecular
    • Almac Group Ltd.
    • BioGenex
    • Covance, Inc.
    • Dako Denmark A/S
    • Epistem Plc.
    • F. Hoffmann-La Roche Ltd.
    • Genomic Health, Inc.
    • MDxHEALTH, Inc.
    • Myriad Genetics, Inc.
    • Precision Therapeutics, Inc.
    • Prometheus Laboratories
    • QIAGEN N.V.
  • 全球市場預測

第3章 各國市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
  • 亞太地區各國
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-7843

This report analyzes the worldwide markets for Predictive Diagnostics in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 49 companies including many key and niche players such as -

Abbott Molecular
Almac Group Ltd.
BioGenex
Covance, Inc.
Dako Denmark A/S

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Curtain Raiser
  • Predictive Diagnostics - A Key Segment of Genetic Testing
  • Outlook for Predictive Diagnostics Market

2. MAJOR MARKET TRENDS, DRIVERS, AND ISSUES

  • Prospects for Predictive Genetic Diagnostics Grow Brighter
  • Increasing Incidence and Prevalence of CDDs: A Major Growth Driver
  • Diagnosed Cases of Cancer on the Rise
    • Table 1: Worldwide Incidence of Cancer in Million: 2012, 2020 & 2030 (includes corresponding Graph/Chart)
    • Table 2: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart)
    • Table 3: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
    • Table 4: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
  • Predictive Diagnostics - Crucial for Breast Cancer Management
    • Table 5: World Breast Cancer Statistics: Top 20 Countries with Highest Breast Cancer Rates (includes corresponding Graph/Chart)
  • Incidence of Neurodegenerative Diseases Increasing
  • Alzheimer's Disease
  • Huntington's Disease
    • Quick Facts on the Global Prevalence of Huntington's Disease
  • Parkinson's Disease
  • Ballooning Global Population Offers Significant Growth Opportunities
    • Table 6: Top 25 Countries Worldwide in Terms of Population (2015E) (includes corresponding Graph/Chart)
  • Predictive Diagnostics Enable Higher Life Expectancy
    • Table 7: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
    • Table 8: Global Population Statistics for the 65+ Age Group: 2013 (includes corresponding Graph/Chart)
    • Table 9: Global 60+ Years Population as a Percentage of Total Population by Geographic Region (2013) (includes corresponding Graph/Chart)
    • Table 10: Global Aging Population (2013): Population in the Age Groups 60-64, 65-79 and 80 above as a Percentage of Total Population by Major Geographic Regions (includes corresponding Graph/Chart)
  • Pharmacogenomics Development Augurs Growth of Predictive Diagnostics
  • Discovery of Novel Biomarkers - Crucial to Predictive Diagnostics
  • Next-Generation Sequencing - A Giant Leap in Genome Sequencing
  • Breast Cancer Gene Testing Market to Expand Strongly
  • Myriad Genetics - The Unquestioned Leader in Breast Cancer Testing
  • Growing Direct-to-Consumer Genetic Testing: Boon or Bane??
  • Genomic Research Remains Confined to Fundamental Research
  • Unresolved Issues Hamper Widespread Implementation of Genetic Diagnosis and Testing for Monogenetic Disease
  • Dearth of Genetic Counselors - A Major Hurdle for the Predictive Genetic Testing
  • Framework for Validation, Regulation, and Ethical Issues - The Need of the Hour

3. PRODUCT OVERVIEW

  • Introduction
  • Underlying Principles of Predictive Diagnostics
  • Predictive Diagnostics Vis-a-vis Conventional Testing
  • Characteristics of an Effective Predictive Diagnostic Test
  • Applications of Predictive Diagnostics
  • Pre-Symptomatic
  • Predisposition Testing
  • Cancer Testing
  • Carrier Identification
  • Pharmacogenetics
  • Pharmacogenomics
  • Prenatal Diagnosis
  • Steps in Genetic Testing Process
  • Limitations
  • Risks and Other Limitations of Genetic Testing
  • Select Diseases Identified Using Predictive Diagnostics
  • Cystic Fibrosis
  • Breast and Ovarian Cancer (BRCA)
  • Alzheimer's Disease
  • Colorectal Cancer
  • Hemochromatosis (HH)
  • Huntington's Disease (HD)
  • Costs of Select Tests
    • Table 11: Costs of Select Genetic Tests
  • Medical Ethics Surrounding Predictive Diagnostics

4. PRODUCT INTRODUCTIONS

  • Genomic Health Reports Positive Clinical Study Results of Oncotype DX Test
  • Genetic Technologies Limited Launches BREVA Genplus
  • Myriad Genetics Reports Positive Trial Results for MyRisk Diagnostic Test
  • SRL Diagnostics Launches ST2 Test to Predict Heart Failure
  • ColDx Assay by Almac Validated as Colon Cancer Biomarker
  • LabCorp. Launches Several Cancer Assays
  • MolecularMD Develops and Validates Assay Tests to Determine LKB1 Expression and Mutation Status
  • Abbott's Galectin-3 Assay Awarded CE Marking
  • Asuragen Introduces BRAF and KRAS Mutation Testing Services

5. RECENT INDUSTRY ACTIVITY

  • MedImmune Completes Acquisition of Definiens
  • LabCorp. to Acquire Covance
  • Myriad to Market EndoPredict Test by Sividon Diagnostics
  • QIAGEN Takes Over Ingenuity Systems
  • Cenix to Partner with Debiopharm
  • MolecularMD Corp. Obtains License for LKB1 Gene Technology
  • Agilent Acquires Dako
  • Celgene Takes Over Avila Therapeutics
  • Signal Genetics Acquires ChipDX
  • Roche and Med Fusion Form Strategic Alliance
  • Epistem Inks Supply and Distribution Agreement with Becton Dickinson for Tuberculosis Test
  • Rosetta Genomics Signs Co-Marketing Agreement with Precision Therapeutics
  • Quintiles Establishes Oxford Cancer Biomarkers for Personalized Medicine Care
  • Cornell University Licenses microRNA Diagnostic IP to Prolias Technologies
  • Signal Genetics Introduces ResultsPX™ Analysis Tool and Physician Web Portal for Genetic Test Results

6. FOCUS ON SELECT KEY PLAYERS

  • Abbott Molecular (US)
  • Almac Group Ltd. (Ireland)
  • BioGenex (US)
  • Covance, Inc. (US)
  • Dako Denmark A/S (Denmark)
  • Epistem Plc. (UK)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Genomic Health, Inc. (US)
  • MDxHEALTH, Inc. (US)
  • Myriad Genetics, Inc. (US)
  • Precision Therapeutics, Inc. (US)
  • Prometheus Laboratories (US)
  • QIAGEN N.V. (The Netherlands)

7. GLOBAL MARKET PERSPECTIVE

    • Table 12: World Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Predictive Diagnostics by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
    • Table 14: World 12-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Dollar Revenues for US, Canada, Japan, Europe, Asia-Pacific, and Rest of World Markets for the Years 2009, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Market Outlook
    • Genetic Information Nondiscrimination Act (GINA) Boosts Genetic Testing
    • High Frequency of Predictive CFTR Screening in Expectant Mothers
    • Cancer Stats - Opportunity Indicator
    • Table 15: New Cancer Cases in the US by Gender and Affected Site: 2014E(includes corresponding Graph/Chart)
    • Table 16: Incidence of Cancer for All Body Sites by Gender & Age Group in the US (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; 65 years and Above (includes corresponding Graph/Chart)
    • Table 17: The US Breast Cancer Incidence in Women by State (2013): New Cases of Breast Cancer in Leading 15 States (includes corresponding Graph/Chart)
    • Product Introductions
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 18: The US Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: The US Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Cancer Statistics in Canada: Opportunity Indicator
    • Table 20: New Cancer Cases in Canada by Gender and Affected Site: 2014E (includes corresponding Graph/Chart)
    • Table 21: New Cancer Cases in Canada by Province: 2014E (includes corresponding Graph/Chart)
    • Table 22: New Cancer Cases in Canada by Age Group: 2014E (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 23: Canadian Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 24: Canadian Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 25: Japanese Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 26: Japanese Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Predictive Testing to Dominate Genetic Testing and Screening Services in Europe
    • Table 27: European Genetic Testing Market by Type (2014 & 2018E): Percentage Breakdown of Diagnostic, Predictive, and Relationship Testing Revenue (includes corresponding Graph/Chart)
    • Hassles Faced by European Genetic Testing Market
    • Cancer Statistics in Europe
    • Table 28: Number of New Cancer Cases in Europe: 2012-2030 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 29: European Recent Past, Current & Future Analysis for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: European Historic Review for Predictive Diagnostics by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)
    • Table 31: European 12-Year Perspective for Predictive Diagnostics by Geographic Region - Percentage Breakdown of Dollar Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2009, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 32: French Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 33: French Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • German Ethics Council Releases Recommendations for Genetic Testing
    • Proposals Mentioned: A Snapshot
    • Strategic Corporate Development
    • IMGM Laboratories GmbH - A Key Player
  • B. Market Analytics
    • Table 34: German Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 35: German Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 36: Italian Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 37: Italian Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • UK Government Encourages Genetic Testing
    • Epistem Plc - A Key Player
  • B. Market Analytics
    • Table 38: The UK Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 39: The UK Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

4e. REST OF EUROPE

  • A. Market Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 40: Rest of European Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 41: Rest of European Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Table 42: Population Statistics in Asia (Including Japan) & Percentage of Population Aged Above 65 Years (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 43: Asia-Pacific Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 44: Asia-Pacific Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Product Introductions
    • Strategic Corporate Developments
    • Emsurg Healthcare (India) Pvt. Limited - A Key Player
  • B. Market Analytics
    • Table 45: Rest of World Recent Past, Current & Future Analysis for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 46: Rest of World Historic Review for Predictive Diagnostics Market Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top